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ALA. Department of Chemistry, Birzeit University, West Bank, via-Israel.--CW. Department 
of Chemistry, University of Tennessee, Knoxville, Tennessee 
ABSTRACT 
The interaction of binuclear copper(II) complex of the anticonvulsant drug valproate, CUE(valp) 4 
(1), with metronidazole (mtnd) or 2-methyl-5-nitrobenzimidazole (2m5nbnz), have led to the 
isolation of two binuclear adducts of the type Cu2(valp)g(mtnd) 2 (2), and CUE(valp)4(2mSnbnz) 2 
(3), and one mononuclear dduct of the type Cu(valp)2(2m5nbnz) 2 (4). Spectral and magnetic data 
and preliminary X-ray measurements for complexes 2 and 3 are consistent with a binuclear 
structure as found for copper(II) tetracarboxylate adducts. The above data for complex 4 are 
consistent with a mononuclear square planar complex that contains two valproate ligands and two 
N-containing 2m5nbnz ligands to give essentially a trarts-CuN202 chromophore. The catalytic 
activities of the complexes toward the aerobic oxidation of 3,5-di-t-butylcatechol t  the corre- 
sponding o-benzoquinone and N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD) to TMPD + 
were determined. The activities were found to be in the order 1 > 2 > 3 > 4. The formation of a 
copper ion-semiquinone species in solution, which may be the catalytic intermediate that reacts 
directly with oxygen, was demonstrated spectrophotometrically. 
INTRODUCTION 
Binuclear copper(I I)  carboxylates with a variety of oxygen and nitrogen donor 
l igands of Cu2(O2CR)4.L 2 stoichiometry have been extensively investigated, and 
the results of their magnetic and spectral properties have been reviewed [1]. In 
the case of some nitrogen donor ligands, especially imidazoles, a number 
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of copper(II) carboxylates form mononuclear c/s or trans bis-adducts of 
Cu(O2CR)2.L 2 stoichiometry [2-5] and tetrakis-adducts of Cu(O2CR)2.L 4 stoi- 
chiometry [6, 7]. Several studies have been designed to investigate the factors 
that influence the adoption of mononuclear over binuclear in copper(II) carbox- 
ylate adducts [2-9]. The results of these studies showed the dependence of
structure on subtle electronic properties of the carboxylate groups, as well as the 
electronic and steric properties of the added bases. It has been generally found 
that by increasing the acidity of the carboxylate groups and/or the basicity of 
the added ligands, the tendency towards the formation of mononuclear dducts 
increases [lc, 2-9]. 
Valproic acid (2-propylpentanoic acid) in the form of its sodium salt has a 
wide spectrum of activity as an anticonvulsant drug [10]. Copper(II) complexes 
of anticonvulsant and antiinflammatory ligands have been found to be more 
active and desirable drugs than the parent ligands themselves [11]. Physical 
studies of copper(II) valproate [12] have shown that it contains binuclear units 
with four bridging carboxylate ligands to two copper(II) ions and similar to other 
copper(II)carboxylates [1]. The only known binuclear monoadducts of copper(II) 
valproate are those with pyridine and aniline [12a]. The pyridine adduct is 
unstable, and its crystal subjected to X-ray structure analysis was sealed in a 
glass capillary to avoid decomposition during data collection [12hi. Recently, we 
reported the synthesis and characterization of four mononuclear copper(II) 
valproate adducts with imidazoles [4]. These complexes are found to exist as 
trans or c/s bis-adducts having essentially CuN20 2 chromophore. 
Interest in developing small molecular weight copper(II) complexes as model 
copper oxidase enzymes had led to the synthesis of both mononuclear and 
binuclear complexes [13-17], including copper(II) carboxylate adducts with 
imidazole type ligands [4, 5, 18-21]. The idea is that these complexes might 
mimic the behavior of various metalloproteins such as the copper-containing 
proteins type I, II, and III. In addition, some binuclear and mononuclear 
copper(II) carboxylate adducts with imidazole-type ligands have been found to 
have a variety of pharmacological effects such as antitumor [22], superoxide 
dismutase [23], and catecholase activities [4, 5, 19-21]. Recently, we reported the 
synthesis and characterization f several mononuclear nd binuclear copper(II) 
carboxylates, and studied their catalytic properties in the aerobic oxidation of 
catechol to the corresponding o-benzoquinone [4, 5, 19-21] as models for 
catecholase function of the copper-containing enzyme tyrosinase [24]. In addi- 
tion to the dependence of the structure of copper(II) carboxylates on the 
electronic and steric properties of added base, the rate of oxidation of catechol 
to o-benzoquinone was also affected by the nature of added base [4, 5, 13, 19, 
20]. Therefore, structural and electronic factors that might impact he properties 
of copper(II) complexes as metalloprotein models are of interest. Since nitroimi- 
dazoles are used as chemotherapeutic agents in the treatment of bacterial 
infections and as radiosensitizers [25], metronidazole (1-(2-hydroxyethyl)-2- 
methyl-5-nitroimidazole) and 2-methyl-5-nitrobenzimidazole are used in this 
study to form copper(II) valproate complexes. In addition, we examined the 
catalytic activities of these complexes for the aerobic oxidation of N,N,N',N'-te- 
tramethyl-p-phenylenediamine (TMPD) to TMPD ÷ and 3,5-di-t-butylcatechol to 
3,5-di-t-o-benzoquinone as models for copper-containing oxidase nzymes. 
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EXPERIMENTAL 
All chemicals were of high purity grade (Aldrich or Sigma Chemical Co.) and 
were used without further purification. Tetrakis-/x-valproato dicopper(II) 
[Cu2(valp)4], (1) was prepared as described previously [12] and recrystallized 
from absolute thanol. 
Preparation of Complexes 
Bis(metronidazole) tetrakis (tz-valproato) dicopper(II), Cu2(ualp)4(mtnd)2, (2). A 
solution of 0.5 g (2.92 mmol) metronidazole in 80 mL methanol was added to 0.5 
g (0.71 mmol) of Cu2(valp) 4. The mixture was stirred and refluxed for 3 h. The 
green solution was filtered under reduced pressure, and the green filtrate was 
concentrated by slow evaporation i the hood to ca. 10 mL and filtered. Slow 
evaporation of the filtrate produced green crystals which were recrystallized 
from chloroform. Anal. Calc. for C44H78N6014Cu2: C, 50.72; H, 7.49; N, 8.07. 
Found: C, 50.33; H, 7.47; N, 8.11%. 
Bis(2-methyl-5-nitrobenzimidazole) tetrakis (iz-valproato) dicopper(II), Cu2(valp) 4
(2m5nbnz) 2, (3). A solution of 0.2532 g (1.43 mmol) of 2-methyl-5-nitrobenzi- 
midazole in 140 mL warm chloroform was added to 0.5 g (0.71 mmol) of 
Cu2(valp) 4.The mixture was stirred at about 50°C for 3 h. The green solution 
was filtered while hot and left in the hood to evaporate. The green precipitate 
that formed was recrystallized from absolute thanol and air dried. Anal. Calc. 
for C48H74N6012Cu 2" C, 54.70; H, 7.03; N, 7.98. Found: C, 54.53; H, 6.99; N, 
7.91%. 
Bis(2-methyl-5-nitrobenzimidazole) bis(valproato) copper(II), Cu(valp)2(2m5nbnz) 2, 
(4). A solution of 0.51 g (2.88 mmol) of 2-methyl-5-nitrobenzimidazole in 120 
mL warm normal butanol was added to 0.5 g (0.71 mmol) of CUE(valp) 4. The 
mixture was stirred for 3 h. The dark green solution was filtered under reduced 
pressure and left in the hood to evaporate. The purple precipitate that formed 
was purified by dissolving it in cold methanol, filtration, and evaporation of the 
solution to dryness. Recrystallization from methanol/hexanes (3:1) produced 
purple crystals. Anal. Calc. for C32H44OaN6Cu: C, 54.58; H, 6.25; N, 11.94. 
Found: C, 54.75; H, 6.47; N, 12.04%. 
Elemental analyses were performed by Galbraith Laboratories, Knoxville, TN, 
U.S. 
Physical Measurements 
Solution room-temperature (298 K) magnetic moments were determined by the 
Evans method [27] with a Bruker AC250 MHz NMR spectrometer. Ethanol was 
used as the solvent and TMS as the reference. The effective magnetic moment is 
related to the reference shift, A v (Hz) at any temperature by the expression 
I~en = O.0618(Av.T/vM) 1/2, where v is the NMR frequency in MHz and M is 
the molarity of the paramagnetic substance. 
Electronic spectra of chloroform or ethanol solutions were obtained with a 
Hewlett Packard 8425A diode array or Bausch and Lomb 2000 spectrophotome- 
ters. Nujol mulls sealed between polyethylene sheets were used to obtain IR 
spectra in the 4000-450 cm-1 region with an FTS-7 Bio-Rad SPC 3200 Fourier 
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transform infrared spectrometer. X-band EPR spectra of polycrystalline mate- 
rial and of ethanol/toluene solutions were obtained at room temperature and at 
liquid nitrogen temperature with a JEOL Jes-PE-1X spectrometer. Diphenylpi- 
crylhydrazide (DPPH, g = 2.0036) was used as the calibrating field marker. 
Catalytic Activities 
The catalytic activities of these complexes for the oxidation of TMPD 
(N,N,N',N'-tetramethyl-p-phenylenediamine) in a r were followed spectrophoto- 
metrically by monitoring the increase in the TMPD + absorbance at 565 nm as a 
function of time [26]. Methanol solutions of the copper(II) complex (1.3 mL of a 
0.5 X 10 -4 M) and 1.3 mL of a methanol solution (2.5 x 10 -3 M) of TMPD 
were combined in a 1 cm quartz cell at 298 k, and the absorbance changes at 565 
nm were recorded. The catecholase-mimetic activities of the complexes for the 
aerobic oxidation of 3,5-di-t-butylcatechol (DTBC) to corresponding 3,5-di-t-o- 
benzoquinone(DTBQ) were followed spectrophotometrically by monitoring the 
increase in the absorbance at 400 nm as a function of time. The metal complex 
(0.5 mL of a 2 x 10 -4 M methanol solution) and 2.5 mL of a methanol solution 
of DTBC (0.04 M) were added together in a 1 cm spectrophotometric cellat 298 
K, and the absorbance changes at 400 nm were recorded. 
RESULTS AND DISCUSSION 
The binuclear compound 2 was obtained from the reaction of metronidazole 
(mtnd) with Cu2(valp) 4 in either ratio 2:1 or 4:1, but the binuclear compound 3
was obtained from the reaction of 2-methyl-5-nitrobenzimidazole (2mSnbnz) 
with CUE(valp) 4 in ratio 2:1, while ratio 4:1 produced the mononuclear com- 
pound 4. The compounds are generally soluble in alcohols, and in addition, 
binuclear compounds are also soluble in chloroform and dichloromethane. 
Magnetic and Spectroscopic Characterization 
The effective magnetic moments and electronic and IR spectral data are 
summarized in Table 1. The room temperature magnetic moments for com- 
plexes 2 and 3 are in the range 1.18-1.26 BM. These subnormal values are 
significantly ower than the spin-only value of 1.73 BM, suggesting that substan- 
tial coupling between the copper atoms occurs. These values are comparable to 
the magnetic moment values of binuclear copper(II) carboxylate adducts of the 
type[Cu(RCOO)2L] 2 [1], including that reported for the structurally known 
binuclear adduct of copper(II) valproate with pyridine [12b]. The room tempera- 
ture magnetic moment for complex 4 (1.84 BM) is consistent with the presence 
of one unpaired electron in a mononuclear copper(II) complex. 
The electronic spectra in chloroform solutions of the compounds 2 and 3 
exhibit one broad band near 700 nm (Table 1). This band can be assigned to 
copper(II) d-d transitions. These complexes do not exhibit the second band at 
about 370 nm, the charge transfer band that is considered to be diagnostic of 
binuclear copper(II) adducts with bridging carboxylates [1, 12]. This band may be 
obscured by the very intense ligand-to-metal charge transfer band in the range 
300-330 nm due to the presence of metronidazole or 2-rnethyl-5-nitrobenzi- 
midazole ligands in these binuclear compounds. The position of the d-d 
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TABLE 1. Magnetic Moments and Electronic and IR Spectral Data for 
Cu(II) Complexes 
/-Left (BM) /~max (nm) Vasym (CO2) b'sym (CO2) 
Compound (298 K) (e =dm 3. tool- 1. cm- 1) (cm- 1) (cm - 1) 
Cu2(valp)4, (1) 1.33 671(410) 1580 1422 
375(146) 
Cu 2(valp)4(mtnd)2, (2) 1.18 708(364) 1610 1418 
Cu2(valp) 4 (2m5nbnz)2, (3) 1.26 720(420) 1610 1415 
Cu(valp) 2(2m5nbnz)2, (4) 1.84 688(200) 1630 1417 
1606 
transitions and the magnitude of their molar absorptivities are in the range 
expected for binuclear copper(II) carboxylate adducts having bridging carboxyl- 
ate groups and axially coordinated nitrogen donor ligands [1, 12, 20]. 
The electronic spectra of complex 4 in ethanol solution exhibit one broad 
absorption band due to copper(II) d-d transitions (Table 1). The position of the 
band is consistent with the assignments for other tetragonally distorted copper(II) 
complexes containing a CuN20 2 . . .0  2 chromophore [lc, 3-6, 19, 20]. It is 
comparable to those found for mononuclear copper(II) valproate complexes 
with imidazoles [4] which contain the trans- or cis-CuN20 2 (or CuN202... 02) 
chromophore. 
The assignment of IR stretching frequencies for the antisymmetric, b'asy m
(CO 2) and the symmetric, Vsym(CO 2) of the valproate group are given in Table 1. 
The b'asy m (CO2)  and the Vsy m (CO 2) frequencies for complexes 2 and 3 occur at 
about 1610 and 1415 cm -1, respectively. The positions of these frequencies and 
the separation between them, ml~(/.Pasym(CO2)- l~sym(CO2) ) of ca. 195 cm -1, 
when compared with those of sodium valproate (Vasym(CO2) , 1570; Vsym(CO2), 
1417; Av, 153 cm-1), are in the range expected for carboxylate groups that act 
as a bridging bidentate ligand [lb, 12, 28]. These parameters are comparable to 
those reported for structurally known binuclear copper(II) valproate complex 
that contain pyridine [12]. The antisymmetric carbooxyl, /.Pasym(CO2) , vibration 
for complex 4 appeared as a doublet at 1630 and 1606 cm -1, and the symmetric, 
V~ym(CO2), vibration appeared at 1417 cm -1 (Table 1). The position of these 
carboxylate stretching vibrations and the separation between them are in the 
range expected for carboxylate groups that act essentially as monodentate or
asymmetric bidentate ligands [4, 19, 28]. They are comparable to those reported 
for mononuclear copper(II) carboxylate complexes that contain imidazoles hav- 
ing the CuN202 (CuN202 ... 02)  chromophore [4, 19]. The stretching vibrations 
of the NO 2 group, IZasyrn(NO2) and Vsym(NO2) , for metronidazole in complex 2 
occur at 1517 and 1355 cm -1, respectively, and the corresponding NO 2 of 
2-methyl-5-nitrobenzimidazole in complexes 3 and 4 occur at 1521 and 1344 
cm -1" 
The X-band EPR spectra of powdered samples of complexes 2 and 3 were 
obtained at room temperature, and a representative spectrum is that of 3 shown 
in Figure I(A). The spectra exhibit absorption typical for the randomly oriented 
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HGURE 1. (A) Solid-state EPR spectrum of compound 3 at room temperature. (B) 
Frozen-solution EPR spectrum of compound 4. 
triplet state (S = 1) of axial symmetry. The absorption features are similar to 
those previously reported for binuclear copper(II) carboxylates [1, 12a, 20]. 
Three absorption lines, namely, Hzl , Hz2 ,and H ±, for complexes 2 and 3 were 
observed. In the EPR spectrum of complex 2, besides the afore-mentioned lines 
typical of the binuclear complex, a signal at magnetic field around 3000 G 
corresponding to a mononuclear dmixture was observed. Mononuclear signals 
are commonly found for binuclear copper(II) carboxylates [1]. However, no such 
signal has been observed in the EPR spectrum of complex 3 [Fig. I(A)], thus 
excluding the presence of any mononuclear impurities. The EPR parameters for 
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complexes 2 and 3 were calculated by the method of Wasson et al. [29] (Table 
2) by using the following equations [lb]: 
hv= D - g l l /3Hzl ,  (1) 
hv= -D  + gll flHz2, (2) 
_2 O2Lr2  ~1/2 h v = - 0.5D + (0.25D 2 + g ± p n ± j (3) 
where h is Planck's constant, v is the microwave frequency, Hzl , Hz2 are the 
low and high field parallels, respectively, H ± is the perpendicular field, and D is 
the axial-field splitting. The parameters g11, g ±, and D values obtained for 
binuclear complexes 2 and 3 are comparable to those reported for other 
binuclear copper(I I) carboxylate complexes [1], including those reported for 
structurally known binuclear copper(II) valproate adduct with pyridine [12]. In 
addition, our preliminary results of X-ray measurements on complex 2 indicated 
a similar binuclear structure. 
The X-band EPR parameters, g and A, for the frozen solution and the 
polycrystalline form of complex 4 are given in Table 2. The frozen solution EPR 
spectrum is shown in Figure I(B), and exhibits resolved structure with gll > g ± • 
These features are consistent with a tetragonally elongated structure [30]. The 
g ± region of the spectrum exhibits a 14N superhyperfine structure that consists 
of five lines. This splitting is attributed to the presence of two nitrogen atoms in 
the plane of the copper(I I) ion. The EPR spectral parameters for this complex 
are comparable to those previously reported for complexes that contain essen- 
tially the CuN 202(or CuN 2 O2. . .  O 2) chromophore in a trans or c/s square-planar 
arrangement, including those reported for mononuclear bis-adducts of copper(II) 
carboxylates with imidazoles [2-6, 19, 20, 22, 23]. In complexes for which 
structural data are available, the copper(II) atom is bonded in a trans or cis 
TABLE 2. EPR and Kinetic Data for the Oxidation of DTBC by Cu(II) Complexes 
State IDI 
Compound (Temperature) g~ g ± gll (cm- 1) Activityb 
Cu2(valp) 4 (1) c Solid 2.130 2.016 2.341 0.344 2.6 
(Room) 
Cu2(valP)4(mtnd)2, (2) Solid 2.220 2.129 2.405 0.345 1.6 
(Room) 
Cu 2(valp)4(2m5nbnz)2, (3) Solid 2.200 2.085 2.430 0.351 0.94 
(Room) 
Cu(valP)2(2m5nbnz) 2 (4  Solid 2.112 gx = 2.052 2.213 - -  0.47 
(Room) gy = 2.070 
Frozen 2.132 2.054 2.288 - -  
(77 K) 
(A11Cu = 166 × 10 -4 era -  1 
A±N= 14 X 10 -4 cm -1) 
go values are calculated from the equation go = ~(2g ± +gll). 
The activity is reported as micromoles ofDTBQ produced per mg catalyst per min. 
¢ The EPR data are taken from Ref [12a]. 
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arrangement to two ligand nitrogen atoms and one oxygen atom from each of 
two carboxylate ligands; the second oxygen atom of each carboxylate ligand is 
weakly bonded in a pseudoaxial rrangement [2-5, 8b, c]. 
The solid-state EPR spectrum of this complex is anistropic with gll and g 
components. The gll region does not exhibit copper(II) hyperfine coupling, 
which is likely due to dipolar interactions between the copper atoms of neigh- 
boring molecules. The g ± region is partially resolved into its x and y compo- 
nents. A similar spectrum is exhibited by bis-adduct of copper(II) valproate with 
2-methylimidazole [4]. We have determined by single crystal X-ray structure 
analysis that this adduct contains the CuN202 chromophore in a trans square- 
planer arrangement [4]. Our preliminary X-ray data for complex 4 clearly 
indicated that in the solid state, this adduct contains the CuN202 chromophore 
in a trans square-planar arrangement, similar to the bis-adduct of copper(II) 
valproate with 2-methylimidazole [4]. 
Catalytic Activity for the Oxidation of DTBC 
The reactivity of the copper(II) complexes 1-4 towards the two-electron oxida- 
tion of 3,5-di-t-butylcatechol (DTBC) to the corresponding o-benzoquinone 
(DTBQ) was investigated because this is one of the reactions that the copper- 
containing enzyme tyrosinase catalyzes [24]. Since DTBQ shows a characteristic 
absorption band at 400 nm (e= 1900 dm3.mo1-1.cm -1 in methanol) [31], the 
aerobic oxidation of DTBC was studied using electronic spectroscopy b  follow- 
ing the appearance of the absorption of the DTBQ at 400 nm over the first 15 
min of the reaction. The activities of complexes 1-4 were determined as 
micromoles of DTBQ produced per mg of catalyst per minute. These values are 
given in Table 2. Although DTBQ is produced for all complexes, the rate at 
which it is produced varies from binuclear to mononuclear catalysts. The rate at 
which DTBQ is produced is also dependent on the nature of the nitrogen-con- 
taining ligand present in the complexes. 
Small molecular weight binuclear and mononuclear copper(II) complexes 
have been studied as models for copper oxidase enzymes, such as the copper- 
containing protein tyrosinase [13-21]. In tyrosinase and in synthetic opper(II) 
binuclear models, it is believed that two proximate metals atoms are needed to 
bond to two hydroxyl oxygen atoms of catechols in the oxidation to o-quinones 
[14-17]. This is consistent with the relatively high catalytic activity of binuclear 
complexes uch as 1-3 (Table 2) compared to mononuclear complexes uch as 
4. In nonplanar mononuclear copper(II) models, it has been proposed that the 
two copper(II) atoms must be located at a distance of less than 5 A for bonding 
to the hydroxyl groups of the catechols, a mode which should facilitate electron 
transfer to dioxygen [17, 32]. The lower catalytic activities of ternary complexes 
2 and 3 compared to that of the binary complex 1 may be attributed to two 
factors. (1) The presence of the axially coordinated ligands in the ternary 
adducts 2, 3 could render the approach of DTBC to copper(II) sites more 
difficult in these two binuclear when compared to the binary complex 1. In 
addition, the axially coordinated ligands in 2 and 3 are likely to dissociate to 
provide sites on copper for DTBC bonding, and also to facilitate any necessary 
ligand rearrangement induced by this bonding. Such dissociation is not required 
in the binary complex 1 which is axially flee. (2) The presence of high electron 
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affinity ligands, metronidazole in complex 2 and 2-methyl-5-nitrobenzimidazole 
in complex 3, should result in a relatively short-circuited catalytic ycle in these 
complexes when compared to complex 1 because once reduced to Cu(I), the 
complexes would be unable to be easily reoxidized to Cu(II) by oxygen. The 
relatively high catalytic activity of 2 compared to 3 (Table 2) may be due to the 
lower electron affinity of metronidazole igand in 2 relative to 2-methyl-5- 
nitrobenzimidazole ligand in 3. 
A potentially important insight into the mechanistic aspects of the catechol 
oxidation process was recently made by Thompson and Calabrese [33] by the 
isolation and characterization f a series of copper(II)-3,5-di-t-butyl-o-semi- 
quinone, Cu(II)-DTBSQ, complexes from reaction of the corresponding catechol 
or benzoquinone with dinuclear and mononuclear copper(II) or copper(I) com- 
plexes, respectively. It was concluded that the single-step two-electron oxidation 
of catechol by copper(II) complexes i not observed, and o-benzoquinone was 
obtained only after exposure of copper(II)-o-semiquinone to dioxygen or by the 
addition of small molecules uch as pyridine. Their studies indicated that the 
formation of copper(II)-o-semiquinone complexes as an intermediate should be 
considered in catecholase-mimetic activity of copper(II) complexes. 
The possible formation of copper ion-3,5-di-t-butyl-o-semiquinone as an inter- 
mediate species during the oxidation process was demonstrated in this study by 
following the UV-vis spectral charges of the catalytic reaction mixture. 
Copper(II) complex (0.01 mmol) and 0.9 mmol DTBC were mixed in 20 mL 
degassed methanol under nitrogen, and the UV-vis spectrum of the intense 
green solution was recorded. Three absorption bands appeared with time: one 
very broad band with moderate intensity centered at about 770 nm, a second 
band with less intensity at about 570 nm, and a third sharp and very intense 
band at about 385 nm. The first and third bands at about 770 and 385 nm, 
respectively, are comparable to those reported by Thompson and Calabrese [33] 
for the [Cu(diamine)(DTBSQ)] CIO 4 complexes (broad maxima between 825 and 
770 nm with moderate intensity and a sharp, intense band in the 380-395 
region). These features are also similar to [Cu(DTBC)(DTBSQ)]-, DTBSQ- 
prepared electrochemically, and Zn(DTBSQ) 2 [34]. These are ligand DTBSQ- 
bands, and differ significantly from those of copper(II)-catecholate complexes, 
which have no intense absorption bands in these regions [34a, 35]. Recently, it 
was suggested that the presence of the first band at ca. 750-1000 nm is 
diagnostic of the semiquinone character of a coordinated dioxolene ligand [36]. 
The second band at about 570 nm may arise from a catecholato t  copper(II) 
charge transfer transition by analogy to assignments made for other copper(II)- 
catecholato complexes [37]. When this solution was exposed to aerial oxygen, the 
bands at 770 and 570 nm decayed, and the band at 385 nm shifted to ca. 400 nm 
(DTBQ band). The decay rates of the above bands were found in the order 
1 > 2 > 3 > 4, which is consistent with their catalytic activities. It should be 
noted here that a small amount of precipitate was formed during the first 20-30 
min of the catalyzed reaction when complexes 3 or 4 were used as a catalyst. 
The exact manner in which the precipitate is formed is not known at this time, 
but it is associated with catalysts which contain 2-methyl-5-nitrobenzimidazole 
ligand, and it will be under investigation. Methanol was evaporated from the 
reaction mixture; the precipitate was extracted with anhydrous diethylether and 
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filtered. Evaporation of the ether filtrate gave DTBQ, whose IR [v(CO) = 1665 
cm-X], UV-vis (400 nm), and IH NMR [CDC13: t~ 1.20 (9H), 1.26 (9H), 6.20 
(1H), 6.98 (1H)] spectra were compared with those of authentic DTBQ. 
Infrared spectroscopy has proven to be a potent probe in determining the 
nature of coordinated ioxolene ligand, i.e., catecholate or semiquinonate [38]. 
The IR spectra of coordinated catecholates are characterized by an intense 
absorption near 1480 cm -1 (ring stretching mode involving the C-C bond 
between the coordinated oxygen atoms) and 1250 cm -1 (C-O stretching mode) 
[38]. Coordinated semiquinones, on the other hand, exhibit a band in the range 
1420-1460 cm -1, attributed to the C=~O stretching mode [39]. IR spectra of 
complexes 1-4 with DTBC in CH2C12 were obtained by mixing the complex 
with DTBC in CH2CI 2 under nitrogen. An IR band characteristic of the 
chatecholate ligand was observed at about 1480 cm -1, and an IR band in the 
range 1465-1455 cm 1 was observed for all reaction mixtures, which is charac- 
teristic for copper-DTBSQ species. These spectral observations are comparable 
to those reported previously, in which the DTBQ ligand present in both 
catecholate and semiquinonate form in transition metal complexes [21, 38]. 
Collectively, the electronic and IR spectral results obtained here and previously 
[21, 33] suggest hat the oxidation of DTBC with these copper(II) complexes 
proceeds by the following mechanism: 
Copper(II) complex + DTBC ~ [Cu  ll (DTBC 2- )] Complex (4) 
internal electron transfer [Cull(DTBC 2 )],  ' [CuI(DTBSQ)] (5) 
[CuI (DTBSQ)]  Oxidation Cu(II)complex + DTBQ (6) 
In equation (4), two carboxylate groups coordinated to the Cu(II) atom are 
used to dehydrogenate the two hydroxyl groups of DTBC, and Cu(II)-catecholato 
complex is formed (band at 570 nm and IR at 1480 cm-1). In equation (5), an 
internal one-electron transfer from the coordinated catecholato dianion 
(DTBC 2-) to copper(II) gives the intermediate CuI(DTBSQ) complex (bands at 
770 and 385 nm and IR band in the range (1465-1455 cm-1), which is in 
equilibrium with CuII(DTBC 2- ) complex. In equation (6), air oxygen is used to 
oxidize copper(l) and DTBSQ to produce the copper(II) complex and DTBQ. 
The internal electron transfer and the generation of copper(I)-semiquinone 
which is in equilibrium with the copper(II)-catecholate [equation (5)] have 
recently been demonstrated byDooley and coworkers [39a]. Anaerobic substrate 
reduction of amine oxidase (a copper-containing enzyme which has imidazole 
ligands in its first coordination shell of copper(II) and 6-hydroxydopaquinone as 
another cofactor [39b]) generates a copper(I)-semiquinone species which is in 
equilibrium with the copper(II)-reduced quinone species. The copper(I)-semi- 
quinone species was proposed to be the catalytic intermediate that reacts 
directly with oxygen, and similar to the one suggested in this study. In addition, 
the internal electron transfer reaction between two isoelectronic ouples, i.e., 
copper(II)-catecholate/copper(I)-semiquinonate, was recently proposed in the 
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reactivity properties of copper-dioxolene adducts [40]. The equilibrium between 
catecholate and semiquinonate complexes of other transition metals (Co, Ni, Fe) 
has been demonstrated in the catalytic oxygenation of catechols by complexes of 
these metals [40, 41]. The formation of the metal-semiquinonate sp cies, which 
is the catalytic intermediate that reacts with oxygen, has been characterized by 
electronic, IR, and ESR spectroscopic methods [41]. In summary, the results of 
this study indicate that the formation of binuclear or mononuclear copper 
ion-o-semiquinone complexes as an intermediate should be considered in the 
catecholase-mimetic activity of binuclear and mononuclear of Cu(II) carboxylate 
complexes. 
Catalytic Activity for the Oxidation of TMPD 
The catalytic activities of copper(II) complexes 1-4 for 0 2 oxidation of the 
one-electron reducing agent N,N,N',N'-tetramethyl-p-phenylendiamine (TMPD) 
to the corresponding cation radical TMPD + was evaluated by measuring the 
increase of the absorbance at 565 nm (due to TMPD ÷ formation [26]) of the 
reaction mixture for the first 15 min. 
The results are similar to those observed in the catalytic oxidations of DTBC, 
i.e., the activities are in the order 1 > 2 > 3 > 4. These results are consistent 
with the previous one showing that binuclear copper(II) complexes are more 
efficient than mononuclear complexes in the oxidation of TMPD [17, 26]. In 
binuclear copper(II) complexes, two molecules of TMPD are expected to coordi- 
nate at the binuclear sites, but one molecule of TMPD is expected to coordinate 
at the mononuclear site. An electron transfer from each TMPD molecule to 
each Cu(II) ion occurs, and produces a binuclear Cu(I) complex and two 
molecules of TMPD + when binuclear Cu(II) complexes are used as catalyst or 
mononuclear Cu(I) complex, and one molecule of TMPD + when mononuclear 
Cu(II) complexes are used as catalyst. Copper(I) is then reoxidized to copper(II) 
by 0 2. The lower catalytic activities of the ternary binuclear complexes 2 and 3 
compared to that of the binary binuclear complex 1 may be attributed to the 
presence of the axially coordinated secondary ligands in the ternary complexes. 
The presence of these ligands could render the approach of TMPD to copper(II) 
sites more difficult in these two binuclear adducts when compared to 1 which is 
axially free. In addition, the Cu(II) complexes of these high electron affinity 
ligands, nitroimidazoles, once reduced to Cu(I) complexes, would be unable to 
be easily reoxidized to Cu(II) complexes by 0 2. The relatively high catalytic 
activity of 2 compared to 3 may be due to the presence of higher electron 
affinity ligand 2-methyl-5-nitrobenzimidazole in complex 3 when compared to 
metronidazole in complex 2. The behavior of copper(II) complexes used in this 
study mimics the activity of copper-containing oxidase enzymes uch as laccase 
[17] since the TMPD oxidation reaction is believed to be one of the model 
reactions for this enzyme [42]. 
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